Endoscopy Devices are medical devices used to examine internal organs for diagnosis and treatment of diseases. Gastroscopes are also known as Esophagogastroduodenoscopes (EGD)/Oesophagogastroduodenoscopes (OEGD). GlobalData uses proprietary data and analytics to provide a comprehensive report on the gastroscopes devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the gastroscopes market in the US was Olympus followed by PENTAX Medical, Fujifilm, KARL STORZ SE, SonoScape Medical, Ambu, Shanghai Aohua Photoelectricity Endoscope and Xylo Technologies.
Gastroscopes are forward-viewing endoscopes with insertion tubes designed primarily for visualization of esophagus, stomach and duodenum. A Flexible Video Gastroscopes has a flexible insertion tube with video recording facility which uses a charge-coupled device camera present on the distal end of the insertion tube to visualize and display magnified images of esophagus, stomach and duodenum on a video screen.
The value of the gastroscopes devices market within the US was expected to be over $300m in 2023.
For the latest complete market share analysis of gastroscopes device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
